Follow

Scandion Oncology A/S

Nasdaq First North GM (Sweden)

Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer dise Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer diseases. Read more

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
News
08 Oct 2020 - 11:32
1 2 3 4
Show

40

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
SCOL
DK0061031895
Nasdaq First North GM
Sweden (SE)
Details of share in Scandion Oncology A/S with ticker SCOL
Status
Active
Order book id
Amount of instruments
32 135 544
Par value
0.0735
Currency
SEK
Segment
First North
First trading date
08 Nov 2018
Type
Price
Pre-money
Time
Files
IPO
5.85 SEK
43.7M SEK
04 Oct - 18 Oct 2018
IPO in Scandion Oncology A/S
Type
Price
Pre-money
Time
Files
Rights issue
4.10 SEK
48.8M SEK
20 Jun - 09 Jul 2019
Share issue in Scandion Oncology A/S
Type
Price
Pre-money
Time
Files
Exercise
5.20 SEK
99.07M SEK
10 Sep - 01 Oct 2020
Option exercise terms for SCOL TO 1
Type
Price
Pre-money
Time
Files
Rights issue
22.00 SEK
471.32M SEK
26 Nov - 10 Dec 2020
Share issue in Scandion Oncology A/S
Type
Price
Pre-money
Time
Files
Market move
03 Feb 2021
Listing of Scandion Oncology A/S on Nasdaq First North GM
Type
Ticker
ISIN
Market
SHARE
SCOL
DK0061031895
Nasdaq First North GM
Sweden (SE)
Details of share in Scandion Oncology A/S with ticker SCOL
Status
Active
Order book id
Amount of instruments
32 135 544
Par value
0.0735
Currency
SEK
Segment
First North
First trading date
08 Nov 2018
Type
Price
Pre-money
Time
Files
IPO
5.85 SEK
43.7M SEK
04 Oct - 18 Oct 2018
IPO in Scandion Oncology A/S
Type
Price
Pre-money
Time
Files
Rights issue
4.10 SEK
48.8M SEK
20 Jun - 09 Jul 2019
Share issue in Scandion Oncology A/S
Type
Price
Pre-money
Time
Files
Rights issue
22.00 SEK
471.32M SEK
26 Nov - 10 Dec 2020
Share issue in Scandion Oncology A/S
Type
Price
Pre-money
Time
Files
Market move
03 Feb 2021
Listing of Scandion Oncology A/S on Nasdaq First North GM
Type
Ticker
ISIN
Market
OPTION
SCOL TO 1
DK0061144078
Nasdaq First North GM
Sweden (SE)
Details of option in Scandion Oncology A/S with ticker SCOL TO 1
Status
Archived
Order book id
5EKY
Amount of instruments
2 381 530
Currency
SEK
Trading period
08 Aug 2019 - 29 Sep 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company at a subscription price of SEK 5.20 per share during the subscription period from September 10, 2020 until October 1, 2020.
Update (05.08.2019): First day of trading in TO 1 in Scandion Oncology.
Update (10.09.2020): The exercise period for warrants in Scandion Oncology A/S begins today.
Update (25.09.2020): Reminder to exercise Scandion Oncology A/S series TO 1 warrants.
Type
Price
Pre-money
Time
Files
Exercise
5.20 SEK
99.07M SEK
10 Sep - 01 Oct 2020
Option exercise terms for SCOL TO 1
People
Bo Rode Hansen
CEO
Peter Høngaard
Chairman of the board
Annie Rasmussen
Board member
Bo Hansen
Board member
Carl Borrebäck
Board member
Christian Vinding Thomsen
Board member
Jørgen Bardenfleth
Board member
Thomas Feldthus
Board member
Company Details
Sector
HEALTH CARE

Address
Fruebjergvej 3
Zip code
2100
City/district
København
Country
Denmark (DK)
Registration number
38613391
LEI code
549300MPWDMQ5LZEGD09
First trade date
08 Nov 2018
Registration date
05 Feb 2017
Short name
Scandion Oncology

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More